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OBJECTIVES: Few studies in recent years, have evaluated the health related quality
of life (HRQoL) of patients with hyperparathyroidism (PHP) using validated instru-
ments. Only one specific questionnaire has been used to assess the HRQoL in these
patients but is more focused on the severity of associated symptoms than on the
impact of PHP on HRQoL. A new specific questionnaire to assess the HRQoL of
patients with PHP has been developed using a standardized methodology.
METHODS: The objective of the questionnaire is to capture all the relevant aspects;
a literature review and a meeting with five endocrinologist experts were carried
out. To assess the impact on HRQoL of symptoms related to PHP in this population,
a semi-structured interview of 24 PHP patients was carried out. From these inter-
views a group of items were identified. Each item was subsequently scored by the
group of experts, according to clarity, frequency and importance in order to per-
form a qualitative reduction of the items. The final items were edited in a ques-
tionnaire format and administered to a sample of 67 PHP patients. A factorial
analysis and a Rasch analysis were performed to obtain the final pilot question-
naire before initiating the validation study. RESULTS: After qualitative reduction,
34 items were obtained. Factor analysis identified two dimensions with a total
variance explained of 51.5%. Rash analysis was used to exclude those items with
inadequate adjustment (INFIT or OUTFIT1.30 and 0.70) or those which were
redundant. The resultant scale was composed of 16 items (the final questionnaire,
PHPQoL). CONCLUSIONS: PHPQoL questionnaire will allow, once the validation
phase is completed and the psychometric properties (validity, feasibility and re-
sponsiveness to change) are assessed, to learn more on the impact of PHP in usual
clinical practice and clinical studies.
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The diabetes disease entity is a serious threat to society, becoming already the
epidemic of the twenty-first century. It currently affects over 220 million people
worldwide. In many countries, including Poland, this incurable disease is one of the
biggest challenges for health care. OBJECTIVES: The aim of this study is to deter-
mine the place of pharmaceutical care for a diabetic patient in the current health
care system in Poland, to examine the need for actual implementation of such
initiatives and the possible benefits arising from them. METHODS: 1) The analysis
of the currently functioning system of care for diabetic patients, and 2) The study of
the quality of life of people with diabetes and their educational needs (carried out
through a questionnaire). RESULTS: Data from 59 people were analyzed (55.9%
men). The significant amount of surveyed diabetes patients (62,71%) declares, that
is covered by community pharmacy. The respondents when asked for some clari-
fication regarding their perception and definition of community pharmacy listed
elements that are not perceived as such by the theoretical scope of this kind of care.
Almost 95% of respondents claims, that the improved knowledge regarding diabe-
tes contributes to manage with the disease. More than 83% of respondents express
the willingness to explore in more depth their knowledge regarding the topic. The
average value of quality of life among population is 67,31 (with reference to EQ-VAS
scale). CONCLUSIONS: Polish health care system among diabetic patients is still on
the low level. Patients face many limitations when attempting to access the med-
ical benefits and they lack education in the topic. The need for the knowledge
extension and the belief in its efficacy are on a very high level. In spite of many
premises of implementation community pharmacy services in Poland, still the role
of pharmacists is in many cases omitted.
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Fixed-dose combinations of antihyperglycaemic therapies were developed to re-
duce pill burden and improve convenience and adherence in patients with type 2
diabetes (T2DM). OBJECTIVES: To quantify the relative importance of dosing
schedules to T2DM patients and to estimate patients’ willingness to pay (WTP) for
improvements in dosing schedules. METHODS: Participants were US patients (age
18 years) with T2DM who were on oral antihyperglycaemic therapy. Each patient
completed a web-enabled, conjoint survey that presented a series of 8 choice ques-
tions, each including a pair of hypothetical oral antihyperglycaemic therapy pro-
files. Each profile was defined by reductions in average glucose, daily-dosing sched-
ule, chance of mild-to-moderate stomach problems, frequency of hypoglycaemia,
weight change, incremental treatment-related risk of congestive heart failure
(CHF), and out-of-pocket cost. Choice questions were based on predetermined ex-
perimental design. Random-parameters logit was used to estimate the relative
importance of each attribute and to calculate patients’ WTP for improvements in
daily dosing. RESULTS:Of the 2080 patients invited to participate in the study, 1115
patients completed the survey. Over the ranges of attribute levels in the survey,
out-of-pocket cost was the most important attribute. The remaining attributes
were ranked in order of importance as: glucose control, hypoglycaemia, chance of
mild-to-moderate stomach problems, weight change, incremental chance of CHF,
and daily-dosing schedule. On average, patients were willing to pay $35.52 (95% CI:
25.65, 44.89) monthly to move from three pills twice daily to one pill twice daily.
Patients were willing to pay $30.72 (95% CI: 21.18, 40.05) monthly to move from
three pills twice daily to two pills once daily. CONCLUSIONS: Although less impor-
tant than other factors associated with oral antihyperglycaemic therapy, reducing
pill burden through reductions in the frequency of dosing or number of pills per
dose is of value to T2DM patients.
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OBJECTIVES: Approximately 60% of people with diabetes experience non-severe
hypoglycemic events, the most troubling of which are non-severe nocturnal events
(NSNHE). Unfortunately, little is known about the specific impacts of NSNHEs on
functioning, well-being and diabetes management. METHODS: Nine focus groups
were conducted in the US and Europe (France, Germany, UK). Transcriptions were
coded based on modified grounded theoretical approach and a theoretical model of
the impact of NSNHEs derived.RESULTS: Seventy-seven people participated: mean
age 46.5 (20 to 65), (26 type 1, 51 type 2), 66.2% on insulin with on average 4.1 (range
1-25) NSNHEs per month. Analysis generated domains of: symptoms, corrective
diabetes management actions taken, sleep disruption, social and work impacts.
Participants reported awakening with sweating, shaking, dizziness, odd dreams,
and vision disturbances. The majority of participants noted difficulty in returning
to sleep following the NSNHE and many did not return to sleep for the remainder of
the night. As a result, most participants reported feeling fatigue and being physi-
cally ill (e.g. headaches) the next day, negatively impacting a wide range of daily
activities. This impact lasted well into the next day and sometimes for as much as
48 hours. Corrective actions often included a reduction in insulin dose and in-
creased blood glucose monitoring in subsequent days. At work, participants re-
ported calling in sick, arriving late, concentration problems, or reduced effort. They
described canceling social event and coping with irritability that affected their
interactions with family and friends. Additionally, sleep quality of partners was
also disrupted due to the event. NSNHEs were considered by most to be more
frightening, dangerous and anxiety provoking than daytime events. Findings were
similar across all countries. CONCLUSIONS: NSNHEs have a significant negative
impact and require further study. Reducing their frequency may help improve
diabetes management and patient quality of life.
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OBJECTIVES: Globally the prevalence of diabetes is increasing and it is expected
that about 370 million people will live with the condition by 2030. Based on this
expectation the public awareness about this disease remains quite low. Diabetes
strongly affects the health-related quality of life (HRQOL) especially along with
co-morbidities and complications. The aim of this study was to examine the HRQoL
of diabetics living in temporary camps of flood affected compared to controls living
in similar conditions. METHODS: We conducted a cross-sectional survey in five
camps in a rural district of Sindh between August and October 2010. In total, 169
persons with diabetes and 136 age and sex matched controls living in the same
camps were randomly selected from these camps. World Health Organization
Quality of Life questionnaire (WHOQOL-BREF) was used to assess HRQoL. Four
domain scores (physical health, psychological, social relations and environment)
were compared for cases (diabetics) and controls (non-diabetics) and the impact of
socio-economic factors was evaluated in both groups. RESULTS: Overall, the mean
(SD) age of study subjects was 51(14.9) years. The mean duration of diabetes among
respondents was 7.74.1 years. All WHOQOL domains were strongly reduced in
diabetic patients as compared to controls, with strongest effects in physical health
(39 versus 78 points of the 0 – 100 score) and psychological domains (29 versus 71)
and weaker effects in social relationships (57 versus 69) and environment domains
(32 versus 41). The impact of diabetes on HRQoL was especially severe among
females and older subjects. Diabetics with low literacy levels had significantly
weaker effects (p0.001) on the different domains compared to educated subjects.
CONCLUSIONS: Based on these findings, a public health intervention and informa-
tion campaign is needed to be launched in the flood affected camps for regular
disease monitoring of persons with diabetes to prevent them from developing
co-morbidities and complications.
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OBJECTIVES: The aim of this study is to characterize the children and the adoles-
cents from Centro Hospitalar da Cova da Beira with Type 1 Diabetes Mellitus, to
understand better which factors influence the level of Health-related Quality of Life
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